Data gathered: July 11
AI Stock Analysis - Insulet (PODD)
Analysis generated March 24, 2025. Powered by Chat GPT.
Insulet Corporation (NASDAQ: PODD) is a medical device company that specializes in the development, manufacturing, and sale of the Omnipod Insulin Management System. The Omnipod system is designed to serve people with diabetes, providing them with a more convenient and discreet way to administer insulin. The company has been focused on expanding its product portfolio and increasing its market share in the growing diabetes care market.
Stock Alerts - Insulet (PODD)
 |
Insulet | July 8 Job postings are up by 32.9% in the last couple of days. |
|
Insulet | July 8 Over the past few months, there has been an downward trend in the business outlook. |
|
Insulet | July 5 Job postings are up by 26.3% in the last couple of days. |
|
Insulet | June 17 Insider Alert: Singh Prem is selling shares |
Download our app to get future alerts delivered in real-time.
Alternative Data for Insulet
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 280 | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 82,000 | Sign up | Sign up | Sign up |
| Employee Rating | 82 | Sign up | Sign up | Sign up |
| Google Trends | 65 | Sign up | Sign up | Sign up |
| Patents | 272 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 7,151 | Sign up | Sign up | Sign up |
| Facebook Followers | 83,500 | Sign up | Sign up | Sign up |
| Instagram Followers | 60,297 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 5 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 1,825 | Sign up | Sign up | Sign up |
| Twitter Followers | 8,037 | Sign up | Sign up | Sign up |
| Twitter Mentions | 18 | Sign up | Sign up | Sign up |
| News Mentions | 2 | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 80 | Sign up | Sign up | Sign up |
| Linkedin Employees | 4,141 | Sign up | Sign up | Sign up |
About Insulet
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes.
| Price | $289.32 |
| Target Price | Sign up |
| Volume | 507,500 |
| Market Cap | $20.9B |
| Year Range | $235.61 - $327.47 |
| Dividend Yield | 0% |
| PE Ratio | 53.49 |
| Analyst Rating | 88% buy |
| Earnings Date | August 7 '25 |
| Industry | Medical Devices |
In the news
 |
Bank of New York Mellon Corp Has $116 Million Position in Insulet Corporation (NASDAQ:PODD)July 10 - ETF Daily News |
|
Principal Financial Group Inc. Reduces Stock Position in Insulet Corporation (NASDAQ:PODD)July 10 - ETF Daily News |
|
Analysts Set Insulet Corporation (NASDAQ:PODD) Price Target at $321.00July 9 - ETF Daily News |
 |
Will Insulet (PODD) Beat Estimates Again in Its Next Earnings Report?July 9 - Yahoo |
|
Insulet to Announce Second Quarter 2025 Financial Results on August 7, 2025July 7 - Yahoo |
|
Vontobel Holding Ltd. Buys 608 Shares of Insulet Corporation (NASDAQ:PODD)July 6 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q1 '25 | 569M | 160M | 409M | 35M | 89M | 1.020 |
| Q4 '24 | 598M | 167M | 431M | 101M | 142M | 1.150 |
| Q3 '24 | 373M | -4.5M | 377M | 78M | 117M | 0.900 |
| Q2 '24 | 489M | 154M | 334M | 189M | 81M | 0.550 |
| Q1 '24 | 442M | 132M | 310M | 52M | 104M | 0.730 |
Insider Transactions View All
| Manea Dan filed to sell 9,090 shares at $300.1. June 16 '25 |
| Singh Prem filed to sell 4,143 shares at $300.1. June 16 '25 |
| BORIO LUCIANA filed to sell 3,087 shares at $305.7. June 10 '25 |
| Kapples John W. filed to sell 23,180 shares at $318.5. May 15 '25 |
| Benjamin Eric filed to sell 20,906 shares at $320. May 14 '25 |
Similar companies
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Christine Smith Democrat |
Apr 19, 24 | Sell | $50K - $100K |
| Markwayne Mullin Republican |
Jan 26, 24 | Sell | $1K - $15K |
| Rohit Khanna Democrat |
Nov 8, 23 | Sell | $1K - $15K |
Read more about Insulet (PODD) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Insulet?
The Market Cap of Insulet is $20.9B.
What is Insulet's PE Ratio?
As of today, Insulet's PE (Price to Earnings) ratio is 53.49.
When does Insulet report earnings?
Insulet will report its next earnings on August 7 '25.
What is the current stock price of Insulet?
Currently, the price of one share of Insulet stock is $289.32.
How can I analyze the PODD stock price chart for investment decisions?
The PODD stock price chart above provides a comprehensive visual representation of Insulet's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Insulet shares. Our platform offers an up-to-date PODD stock price chart, along with technical data analysis and alternative data insights.
Does PODD offer dividends to its shareholders?
As of our latest update, Insulet (PODD) does not offer dividends to its shareholders. Investors interested in Insulet should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Insulet?
Some of the similar stocks of Insulet are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.
.